Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bette A. McCue"'
Autor:
Bette A McCue, Kenneth N Sall, Susan C Orr, Harold R. Katz, R. Faulkner, D.C. Dahlin, Samuel Masket, Stephen S. Lane
Publikováno v:
Cornea. 24:955-958
Purpose To investigate the absorption of moxifloxacin into human aqueous humor after administration of moxifloxacin hydrochloride ophthalmic solution, 0.5% as base. Methods Cataract patients were randomly allocated to receive 1 drop every 15 minutes
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 565:255-264
A sensitive and selective gas chromatographic-electron-capture assay was developed for the determination of the aldose reductase inhibitor imirestat in lens and plasma. The method involves solid-phase extraction of drug and internal standard from the
Autor:
James E. Chastain, Bette A McCue, Helga Wieland, R. Faulkner, Louis Desantis, Johan Przydryga, Jess T. Whitson, M. Curtis, Mark E. Sanders, D.C. Dahlin, G. Hollo
Publikováno v:
Investigative ophthalmologyvisual science. 47(1)
PURPOSE. To measure the concentration of betaxolol in tissues of humans with glaucoma and normal monkeys after topical administration. METHODS. Enucleated eyes (n 7) of patients with glaucoma (age range, 27–79 years), without apparent anatomic disr
Publikováno v:
Journal of Pharmaceutical Sciences. 77:591-595
Two selective high-performance liquid chromatographic (HPLC) methods have been developed for the quantitative determination of spiro-(2-fluoro-9H-fluorene-9,4′-imidazolidine)-2′,5′-dione (AL01567; 1 ) in plasma and urine, with an assay sensitiv
Autor:
C. Mitchell Gilbert, Hong-Ming Cheng, P.P. Elena, Philippe Denis, Jan Krolczyk, Hua Xiong, Kurt J. Bloch, Bette A. McCue, Peter Müller, Matthias Böhnke, M. Kosina-Boix, Otto Hockwin, G. Moulin, Katrin Engelmann, Mark B. Abelson, Stefan D. Trocme, Peter Friedl, Philip R. Mayer, Mathea R. Allansmith, Philippe Lapalus
Publikováno v:
Ophthalmic Research. 21:315-344
Publikováno v:
Ophthalmic Research. 21:285-291
Investigations on the disposition of the highly effective aldose reductase inhibitor AL01576 were carried out in pigmented rats after oral dosing and topical administration of a 0.1% ophthalmic suspension by means of an assay modified from a previous